Non-compliance with clinical guidelines increases the risk of complications after primary total hip and knee joint replacement surgery.
Aged
Arthroplasty, Replacement, Hip
/ methods
Arthroplasty, Replacement, Knee
/ methods
Australia
Cohort Studies
Embolism
/ prevention & control
Female
Guideline Adherence
/ statistics & numerical data
Hospitals, Private
Humans
Male
Middle Aged
Patient Compliance
/ statistics & numerical data
Postoperative Complications
/ etiology
Prospective Studies
Reoperation
Risk Factors
Surgical Wound Infection
/ prevention & control
Venous Thrombosis
/ prevention & control
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
26
03
2021
accepted:
03
11
2021
entrez:
18
11
2021
pubmed:
19
11
2021
medline:
22
1
2022
Statut:
epublish
Résumé
Total hip and total knee replacement (THR/TKR) are common and effective surgeries to reduce the pain and disability associated with arthritis but are associated with small but significant risks of preventable complications such as surgical site infection (SSI) and venous-thrombo-embolism (VTE). This study aims to determine the degree to which hospital care was compliant with clinical guidelines for the prevention of SSI and VTE after THR/TKR; and whether non-compliant prophylaxis is associated with increased risk of complications. A prospective multi-centre cohort study was undertaken in consenting adults with osteoarthritis undergoing elective primary TKR/THR at one of 19 high-volume Australian public or private hospitals. Data were collected prior to surgery and for one-year post-surgery. Four adjusted logistic regression analyses were undertaken to explore associations between binary non-compliance and the risk of surgical complications: (1) composite (simultaneous) non-compliance with both (VTE and antibiotic) guidelines and composite complications [all-cause mortality, VTE, readmission/reoperation for joint-related reasons (one-year) and non-joint-related reasons (35-days)], (2) VTE non-compliance and VTE outcomes, (3) antibiotic non-compliance and any SSI, and (4) antibiotic non-compliance and deep SSI. Data were analysed for 1875 participants. Guideline non-compliance rates were high: 65% (VTE), 87% (antibiotics) and 95% (composite guideline). Composite non-compliance was not associated with composite complication (12.8% vs 8.3%, adjusted odds ratio [AOR] = 1.41, 95%CI 0.68-3.45, p = 0.40). Non-compliance with VTE guidelines was associated with VTE outcomes (5% vs 2.4%, AOR = 2.83, 95%CI 1.59-5.28,p < 0.001). Non-compliance with antibiotic guidelines was associated with any SSI (14.8% vs 6.1%, AOR = 1.98, 95%CI 1.17-3.62,p = 0.02) but not deep infection (3.7% vs 1.2%,AOR = 2.39, 95%CI 0.85-10.00, p = 0.15). We found high rates of clinical variation and statistically significant associations between non-compliance with VTE and antibiotic guidelines and increased risk of VTE and SSI, respectively. Complications after THR/TKR surgery may be decreased by improving compliance with clinical guidelines.
Sections du résumé
BACKGROUND
Total hip and total knee replacement (THR/TKR) are common and effective surgeries to reduce the pain and disability associated with arthritis but are associated with small but significant risks of preventable complications such as surgical site infection (SSI) and venous-thrombo-embolism (VTE). This study aims to determine the degree to which hospital care was compliant with clinical guidelines for the prevention of SSI and VTE after THR/TKR; and whether non-compliant prophylaxis is associated with increased risk of complications.
METHODS AND FINDINGS
A prospective multi-centre cohort study was undertaken in consenting adults with osteoarthritis undergoing elective primary TKR/THR at one of 19 high-volume Australian public or private hospitals. Data were collected prior to surgery and for one-year post-surgery. Four adjusted logistic regression analyses were undertaken to explore associations between binary non-compliance and the risk of surgical complications: (1) composite (simultaneous) non-compliance with both (VTE and antibiotic) guidelines and composite complications [all-cause mortality, VTE, readmission/reoperation for joint-related reasons (one-year) and non-joint-related reasons (35-days)], (2) VTE non-compliance and VTE outcomes, (3) antibiotic non-compliance and any SSI, and (4) antibiotic non-compliance and deep SSI. Data were analysed for 1875 participants. Guideline non-compliance rates were high: 65% (VTE), 87% (antibiotics) and 95% (composite guideline). Composite non-compliance was not associated with composite complication (12.8% vs 8.3%, adjusted odds ratio [AOR] = 1.41, 95%CI 0.68-3.45, p = 0.40). Non-compliance with VTE guidelines was associated with VTE outcomes (5% vs 2.4%, AOR = 2.83, 95%CI 1.59-5.28,p < 0.001). Non-compliance with antibiotic guidelines was associated with any SSI (14.8% vs 6.1%, AOR = 1.98, 95%CI 1.17-3.62,p = 0.02) but not deep infection (3.7% vs 1.2%,AOR = 2.39, 95%CI 0.85-10.00, p = 0.15).
CONCLUSIONS
We found high rates of clinical variation and statistically significant associations between non-compliance with VTE and antibiotic guidelines and increased risk of VTE and SSI, respectively. Complications after THR/TKR surgery may be decreased by improving compliance with clinical guidelines.
Identifiants
pubmed: 34793555
doi: 10.1371/journal.pone.0260146
pii: PONE-D-21-07165
pmc: PMC8601457
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0260146Déclaration de conflit d'intérêts
JF is an unpaid member of the group that developed the NHMRC Guidelines for the prevention of VTE. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Références
Clin Infect Dis. 2006 Aug 1;43(3):322-30
pubmed: 16804848
J Arthroplasty. 2020 Aug;35(8):1983-1985
pubmed: 32340827
J Am Acad Orthop Surg. 2019 Jan 1;27(1):1-11
pubmed: 30260912
Arthroplast Today. 2017 Jun 20;3(2):137-140
pubmed: 28695187
Osteoarthritis Cartilage. 2014 Mar;22(3):389-406
pubmed: 24389057
J Arthroplasty. 2017 Mar;32(3):702-708
pubmed: 27776908
ANZ J Surg. 2019 Oct;89(10):1204-1210
pubmed: 30989803
Am J Health Syst Pharm. 2013 Feb 1;70(3):195-283
pubmed: 23327981
Arthritis Care Res (Hoboken). 2015 May;67(6):782-90
pubmed: 25470687
Am J Orthop (Belle Mead NJ). 2010 Sep;39(9 Suppl):5-13
pubmed: 21290026
Orthop Traumatol Surg Res. 2018 Feb;104(1S):S1-S7
pubmed: 29155312
N Engl J Med. 2015 Oct 22;373(17):1597-606
pubmed: 26488691
J Bone Joint Surg Am. 2019 Mar 6;101(5):429-437
pubmed: 30845037
Clin Appl Thromb Hemost. 2017 Sep;23(6):532-541
pubmed: 27899520
Am J Manag Care. 2011 Jul;17 Suppl 9:S251-8
pubmed: 21819165
Thromb Res. 2016 May;141:163-70
pubmed: 27058273
Bone Joint J. 2017 May;99-B(5):614-622
pubmed: 28455470
Bone Joint J. 2017 Apr;99-B(4 Supple B):3-10
pubmed: 28363888
Am J Health Syst Pharm. 2020 Mar 5;77(6):434-440
pubmed: 31950139
Med Care. 2014 Feb;52(2 Suppl 1):S66-73
pubmed: 24430269
J Rheumatol. 2019 Sep;46(9):1134-1140
pubmed: 30988126
J Antimicrob Chemother. 2018 Jun 1;73(suppl_6):vi3-vi16
pubmed: 29878216
BMC Health Serv Res. 2013 Jun 04;13:203
pubmed: 23734903
Bone Joint J. 2014 Apr;96-B(4):479-85
pubmed: 24692614
Curr Rev Musculoskelet Med. 2017 Sep;10(3):346-355
pubmed: 28664450
Int Wound J. 2015 Jun;12(3):357-62
pubmed: 24612792
J Arthroplasty. 2019 Mar;34(3):560-563
pubmed: 30503320
Bone Joint Res. 2015 Nov;4(11):181-9
pubmed: 26585304
J Arthroplasty. 2017 Apr;32(4):1063-1066
pubmed: 27866951
J Am Acad Orthop Surg. 2014 Dec;22(12):772-81
pubmed: 25425612
Am J Surg. 2012 Nov;204(5):591-7
pubmed: 22906249
Am J Surg. 2014 Nov;208(5):835-840
pubmed: 25113797
BMJ Open. 2016 Mar 09;6(3):e008618
pubmed: 26962033
J Orthop Surg Res. 2019 Apr 2;14(1):93
pubmed: 30940168
Med J Aust. 2012 Jul 16;197(2):100-5
pubmed: 22794056
JAMA Surg. 2019 Jul 1;154(7):590-598
pubmed: 31017647
J Hosp Infect. 2016 Aug;93(4):423-7
pubmed: 27101885
Braz J Infect Dis. 2015 Sep-Oct;19(5):517-24
pubmed: 26254691
Thromb Res. 2016 Jan;137:113-118
pubmed: 26654717
J Bone Joint Surg Am. 2019 May 1;101(9):828-842
pubmed: 31045673
JAMA. 2010 Jun 23;303(24):2479-85
pubmed: 20571014
Bone Joint J. 2019 Jan;101-B(1_Supple_A):3-9
pubmed: 30648488
J Bone Joint Surg Am. 2012 Aug 1;94(15):1359-66
pubmed: 22740029
J Bone Joint Surg Am. 2010 Nov 17;92(16):2643-52
pubmed: 21084575
BMC Musculoskelet Disord. 2019 Feb 23;20(1):90
pubmed: 30797228
Anaesth Intensive Care. 2015 Jul;43(4):461-7
pubmed: 26099757
Clin Orthop Relat Res. 2015 Nov;473(11):3360-3
pubmed: 26250138
Circulation. 2011 Jun 14;123(23):2736-47
pubmed: 21670242
PLoS One. 2015 Dec 29;10(12):e0145759
pubmed: 26713434
Curr Rev Musculoskelet Med. 2014 Jun;7(2):108-16
pubmed: 24706152